1. Academic Validation
  2. Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication

Hexamethylene amiloride blocks E protein ion channels and inhibits coronavirus replication

  • Virology. 2006 Sep 30;353(2):294-306. doi: 10.1016/j.virol.2006.05.028.
Lauren Wilson 1 Peter Gage Gary Ewart
Affiliations

Affiliation

  • 1 ANU Medical School, Pathology Building 10, 6th floor, The Canberra Hospital, Woden ACT 2606, Australia. lauren.wilson@anu.edu.au
Abstract

All coronaviruses encode a small hydrophobic envelope (E) protein, which mediates viral assembly and morphogenesis by an unknown mechanism. We have previously shown that the E protein from Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) forms cation-selective ion channels in planar lipid bilayers (Wilson, L., McKinlay, C., Gage, P., Ewart, G., 2004. SARS coronavirus E protein forms cation-selective ion channels. Virology 330(1), 322-331). We now report that three other E proteins also form cation-selective ion channels. These E proteins were from coronaviruses representative of taxonomic groups 1-3: human coronavirus 229E (HCoV-229E), mouse hepatitis virus (MHV), and infectious bronchitis virus (IBV), respectively. It appears, therefore, that coronavirus E proteins in general, belong to the virus ion channels family. Hexamethylene amiloride (HMA)--an inhibitor of the HIV-1 Vpu virus ion channel--inhibited the HCoV-229E and MHV E protein ion channel conductance in bilayers and also inhibited replication of the parent coronaviruses in cultured cells, as determined by plaque assay. Conversely, HMA had no Antiviral effect on a recombinant MHV with the entire coding region of E protein deleted (MHVDeltaE). Taken together, the data provide evidence of a link between inhibition of E protein ion channel activity and the Antiviral activity of HMA.

Figures
Products